Clínica Baviera reported earnings results for the first half of 2016. For the period, the company achieved sales of EUR 48 million, 12.4% greater than the sales figure for the same period in the previous year, with a solid growth rate in both the domestic market (+12.9%) and the international market (+11.1%). EBITDA increased 78.3% up to EUR 10 million, with a substantial improvement in margins, due to the growth of refractive laser surgery and the positive impact of operating leverage. In turn, EBIT and net profit were EUR 7 million and EUR 5 million, representing an increase of 150.3% and 157.7%, respectively, compared to the first half year of 2015. At June 30, 2016, the company had net cash position of EUR 2 million compared to a net debt of EUR 4 million in June 2015.